1. Home/
  2. Compounds/
  3. tretinoin:navitoclax (4:1 mol/mol)

tretinoin:navitoclax (4:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2tretinoin:navitoclax (4:1 mol/mol)
PharmacoGx tretinoin:navitoclax (4:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to tretinoin:navitoclax (4:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA HRH3 CTRPv2 pan-cancer AAC 0.22 3e-09
mRNA SH3GL2 CTRPv2 pan-cancer AAC 0.21 3e-09
mRNA ELAVL3 CTRPv2 pan-cancer AAC 0.26 3e-09
mRNA FIZ1 CTRPv2 pan-cancer AAC 0.21 4e-09
mRNA SOGA3 CTRPv2 pan-cancer AAC 0.25 4e-09
mRNA TAGLN3 CTRPv2 pan-cancer AAC 0.21 4e-09
mRNA OR2B11 CTRPv2 pan-cancer AAC 0.2 4e-09
mRNA ZNF737 CTRPv2 pan-cancer AAC 0.21 4e-09
mRNA TMSB15A CTRPv2 pan-cancer AAC 0.22 4e-09
mRNA TUBA1A CTRPv2 pan-cancer AAC 0.23 4e-09
Download CSV